Juvenile dermatomyositis: immunopathogenesis, role of myositis-specific autoantibodies, and review of rituximab use. - Wikidata - awgldk - TriplyDB

Juvenile dermatomyositis: immunopathogenesis, role of myositis-specific autoantibodies, and review of rituximab use.

Juvenile dermatomyositis: immunopathogenesis, role of myositis-specific autoantibodies, and review of rituximab use.

http://www.wikidata.org/entity/Q37906737

about

Developments in the classification and treatment of the juvenile idiopathic inflammatory myopathies Novel applications of Rituximab in dermatological disorders Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial.Current treatment strategies: collagen vascular diseases in children Predictors of clinical improvement in rituximab-treated refractory adult and juvenile dermatomyositis and adult polymyositis.Idiopathic Inflammatory Myopathies: an Update on Classification and Treatment with Special Focus on Juvenile Forms.Treatment of Juvenile Dermatomyositis: An Update.Pharmacological management of dermatomyositis.Rituximab-induced regression of CREST-related calcinosis.Cutaneous improvement in refractory adult and juvenile dermatomyositis after treatment with rituximab.

P2860

Q26863125-C4F452FB-BA1B-4144-8C75-AC184BCC563D Q34087599-7E3A2DD7-5A4F-46C9-8914-85875A262D8C Q34644962-D28EF04F-057F-4087-944E-1430DAA21E39 Q36458591-1D2290FC-EE35-4849-AB89-AC7F0927889C Q37704799-A75558C0-EAF3-43C5-A6F7-8F5FE02D6E83 Q38597575-039BE291-F478-4380-AE6C-B57E3A1F4616 Q38678257-6D53A810-EEF8-49F3-8C3D-713BD4C6723F Q39425296-97ED2A2F-43A8-426A-9703-DC52E1EDC41D Q51294294-16C5AEB8-E10E-4312-BAB2-A0A0E28F7F6E Q51331143-9C930A49-E20A-44BF-88DE-5CBF422E8CE4

P2860

Juvenile dermatomyositis: immunopathogenesis, role of myositis-specific autoantibodies, and review of rituximab use.

http://www.wikidata.org/entity/Q37906737

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Juvenile dermatomyositis: immu ...... , and review of rituximab use.

@en

Juvenile dermatomyositis: immu ...... , and review of rituximab use.

@nl

type

label

Juvenile dermatomyositis: immu ...... , and review of rituximab use.

@en

Juvenile dermatomyositis: immu ...... , and review of rituximab use.

@nl

prefLabel

Juvenile dermatomyositis: immu ...... , and review of rituximab use.

@en

Juvenile dermatomyositis: immu ...... , and review of rituximab use.

@nl

P1433

Q37906737-3863EBFA-BF06-437A-98EC-195445F97357

P1476

Q37906737-7B837A7E-8C4C-43EA-A98B-C7D49B872B6E

P2093

Q37906737-3CD7FD4F-6912-4B6C-B5DA-A2BE038EEBE1

Q37906737-6111D7DB-84C1-463C-ACEA-98A6110366D3

P2860

Q37906737-02FBD8C0-BE46-4447-A7EA-0EDBCDD631E9

Q37906737-06CDAF03-0E08-4DCA-B156-FCB4F7102524

Q37906737-0FF4E320-165D-455A-905A-0AB05B583EFF

Q37906737-11CE8BAD-770B-4BA0-9F40-544C911A4695

Q37906737-134BF425-FE38-4FAC-9D84-BA4C9BEF095C

Q37906737-21010218-0BB1-41E9-B41C-FFBAD3AE089D

Q37906737-21E5D4F2-0E70-4D6C-969D-07A256A3EE09

Q37906737-25D91870-E13D-4914-96D9-F2984E4F85A4

Q37906737-3B2B00CC-25E3-4315-BEB9-2FD9CB4CC023

Q37906737-3E8A13E0-56B3-4E8A-B3CA-1EFC3683FB72

P304

Q37906737-FE7C2B4D-422B-4AC1-A5B1-C16D84C99A0A

P31

Q37906737-953AAC08-A250-4503-8526-D539D82C66C4

P356

Q37906737-6139DAD9-3A82-4962-8027-06FA332D1948

P433

Q37906737-57FDA4EE-119B-4CF7-BAE5-188CD0BC584C

P478

Q37906737-11136CFF-F8F1-40EE-B654-18478AB5406C

P577

Q37906737-B8E10818-9BB1-4544-9583-3803C8C3EBEE

P698

Q37906737-79972AFD-1540-4ACF-BFBC-C3B3DE2A0CED

P921

Q37906737-23BBE8F8-D4E9-42CB-BA68-342F46509AF3

Q37906737-4F230504-BD52-476C-A935-BBA5B2FA5797

P356

J.1525-1470.2011.01501.X

P1433

Pediatric Dermatology

P1476

Juvenile dermatomyositis: immu ...... , and review of rituximab use.

@en

P2093

Dominic O Co

http://www.w3.org/2001/XMLSchema#string

Yvonne E Chiu

http://www.w3.org/2001/XMLSchema#string

P2860

FAM/USP9x, a deubiquitinating enzyme essential for TGFbeta signaling, controls Smad4 monoubiquitination

The dermatomyositis-specific autoantigen Mi2 is a component of a complex containing histone deacetylase and nucleosome remodeling activities

An interferon signature in the peripheral blood of dermatomyositis patients is associated with disease activity

FOXP3+ regulatory T cells in the human immune system

Plasmacytoid dendritic cells in inflamed muscle of patients with juvenile dermatomyositis.

Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials.

Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project

RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: Association with rapidly progressive interstitial lung disease.

Interferon-stimulated gene 15 (ISG15) conjugates proteins in dermatomyositis muscle with perifascicular atrophy.

Myositis autoantibodies in Korean patients with inflammatory myositis: anti-140-kDa polypeptide antibody is primarily associated with rapidly progressive interstitial lung disease independent of clinically amyopathic dermatomyositis.

P304

357-367

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1525-1470.2011.01501.X

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P577

2011-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21793879

http://www.w3.org/2001/XMLSchema#string

P921

dermatomyositis